Bristol-Myers Squibb

Tackling Cancer: Kidney Cancer's Biggest Current and Upcoming Players

Tackling Cancer: Kidney Cancer's Biggest Current and Upcoming Players

Motley Fool

Bristol-Myers Has The Future Of Oncology Therapies

Bristol-Myers Has The Future Of Oncology Therapies

Seeking Alpha

FDA OKs Bristol's HIV drug for younger patients

FDA OKs Bristol's HIV drug for younger patients

Yahoo/AP

Undervaluation Of Vical's Full Pipeline Allows A Cheap Bet On Cancer Trial

Undervaluation Of Vical's Full Pipeline Allows A Cheap Bet On Cancer Trial

Seeking Alpha

Gilead-Bristol Hepatitis C Drug Combo Cures All in Study

Gilead-Bristol Hepatitis C Drug Combo Cures All in Study

Bloomberg

Gilead-Bristol Hepatitis C Drug Combo Cures 100% in Study

Gilead-Bristol Hepatitis C Drug Combo Cures 100% in Study

Bloomberg

4 Pharmaceutical Stocks to Buy Now

4 Pharmaceutical Stocks to Buy Now

InvestorPlace

Bristol-Myers Squibb's New Drugs Can Help Reverse Its Sinking Revenue

Bristol-Myers Squibb's New Drugs Can Help Reverse Its Sinking Revenue

Seeking Alpha

Bristol-Myers Squibb

The 3 Drivers Behind The Big Pharma Rally

The 3 Drivers Behind The Big Pharma Rally

Seeking Alpha

Bristol profit drops sharply, but meets Wall Street forecast

Bristol profit drops sharply, but meets Wall Street forecast

Reuters